[go: up one dir, main page]

DE69216600D1 - Synthetisches CDw52(CAMPATH-1) Peptidantigen - Google Patents

Synthetisches CDw52(CAMPATH-1) Peptidantigen

Info

Publication number
DE69216600D1
DE69216600D1 DE69216600T DE69216600T DE69216600D1 DE 69216600 D1 DE69216600 D1 DE 69216600D1 DE 69216600 T DE69216600 T DE 69216600T DE 69216600 T DE69216600 T DE 69216600T DE 69216600 D1 DE69216600 D1 DE 69216600D1
Authority
DE
Germany
Prior art keywords
ser
ala
asn
pct
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69216600T
Other languages
English (en)
Other versions
DE69216600T2 (de
Inventor
Geoffrey Hale
Masahide Tone
Meng-Qi Xia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69216600D1 publication Critical patent/DE69216600D1/de
Application granted granted Critical
Publication of DE69216600T2 publication Critical patent/DE69216600T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69216600T 1991-04-16 1992-04-16 Synthetisches CDw52(CAMPATH-1) Peptidantigen Expired - Lifetime DE69216600T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919108056A GB9108056D0 (en) 1991-04-16 1991-04-16 Synthetic antigen
PCT/GB1992/000705 WO1992018530A1 (en) 1991-04-16 1992-04-16 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN

Publications (2)

Publication Number Publication Date
DE69216600D1 true DE69216600D1 (de) 1997-02-20
DE69216600T2 DE69216600T2 (de) 1997-07-03

Family

ID=10693343

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69216600T Expired - Lifetime DE69216600T2 (de) 1991-04-16 1992-04-16 Synthetisches CDw52(CAMPATH-1) Peptidantigen

Country Status (10)

Country Link
US (1) US5494999A (de)
EP (1) EP0580672B1 (de)
JP (1) JP3329811B2 (de)
AT (1) ATE147406T1 (de)
DE (1) DE69216600T2 (de)
DK (1) DK0580672T3 (de)
ES (1) ES2100340T3 (de)
GB (1) GB9108056D0 (de)
GR (1) GR3023063T3 (de)
WO (1) WO1992018530A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002981C2 (de) * 1990-02-01 1998-03-12 Ihf Inst Fuer Hormon Und Fortp Humane, Epididymis-spezifische Polypeptide und deren Verwendung zur Therapie und Diagnose männlicher Infertilität
GB9215071D0 (en) * 1992-07-15 1992-08-26 Wellcome Found Recombinant antigen
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US6225444B1 (en) * 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
EP1423107B1 (de) * 2001-03-23 2012-05-09 Luitpold Pharmaceuticals, Inc. Fettalkohol-arzneimittel-konjugate
EP1427407A4 (de) 2001-03-23 2005-05-11 Luitpold Pharm Inc Fettamin-arzneimittel-konjugate
JP3977162B2 (ja) * 2002-06-21 2007-09-19 株式会社バンダイナムコゲームス キャラクタ情報管理装置、プログラム及び情報記憶媒体
AU2015207936A1 (en) * 2009-05-13 2015-08-27 Genzyme Corporation Anti-human CD52 immunoglobulins
KR101537840B1 (ko) * 2009-05-13 2015-07-22 젠자임 코포레이션 항-인간 ｃｄ52 면역글루불린
AR095199A1 (es) 2013-03-15 2015-09-30 Genzyme Corp Anticuerpos anti-cd52

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10199051I2 (de) * 1988-02-12 2005-05-04 Btg Int Ltd Modifizierte Antik¦rper.

Also Published As

Publication number Publication date
JPH06510521A (ja) 1994-11-24
GR3023063T3 (en) 1997-07-30
EP0580672B1 (de) 1997-01-08
EP0580672A1 (de) 1994-02-02
ATE147406T1 (de) 1997-01-15
US5494999A (en) 1996-02-27
WO1992018530A1 (en) 1992-10-29
ES2100340T3 (es) 1997-06-16
JP3329811B2 (ja) 2002-09-30
DE69216600T2 (de) 1997-07-03
DK0580672T3 (da) 1997-07-07
GB9108056D0 (en) 1991-06-05

Similar Documents

Publication Publication Date Title
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE69222956D1 (de) Kleinste erkennungseinheit eines pem-mucin-"tandem repeat"-spezifischen monoklonalen antikoerpers
DE69227041D1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
ATE147406T1 (de) Synthetisches cdw52(campath-1) peptidantigen
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
EP0253325A3 (de) Von Onkogenen abgeleitete Peptide
EP0303983A3 (en) Synthetic peptides, antibodies directed against them and their use
FI925321A0 (fi) Immunodiagnostiskt ledinflammationstest
PT635025E (pt) Processo para preparar proteinas modificadas
EP0585364A4 (de) Das durch den monoklonalen menschlichen antikörper 81av78 erkannte antigen ctaa 81av78.
DK329789D0 (da) Monoklonalt antistof
ATE309371T1 (de) Protein mit dnase-aktivität
ES536028A0 (es) Un procedimiento para producir interferon inmune humano recombinante intacto
PT650523E (pt) Antigene cdw52 recombinante

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 580672

Country of ref document: EP